You can buy or sell EBS and other stocks, options, and ETFs commission-free!
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats.
Robert G. Kramer
52 Week High
52 Week Low
New York TimesJun 11
F.D.A. Tells Johnson & Johnson That60 Million Vaccine Doses Cannot Be Used
WASHINGTON — Federal regulators said on Friday that millions of doses of Johnson & Johnson’s coronavirus vaccine produced at a troubled Baltimore factory could
FDA authorizes two batches of Johnson & Johnson Covid-19 vaccine doses from Baltimore plant
(CNN) The US Food and Drug Administration announced Friday it was authorizing for use two batches of Johnson & Johnson Covid-19 vaccines that were produced at t
Business InsiderJun 11
Johnson & Johnson has to throw away 60 million vaccine doses because of possible contamination at the beleaguered Emergent BioSolutions plant
The Food and Drug Administration has told Johnson & Johnson to throw out about 60 million COVID-19 vaccine doses from a beleaguered plant, people familiar with
— per share
Expected Jul 29, After Hours